神经血管导管市场规模、份额及成长分析（按类型、组件、应用、最终用途和地区划分）－2026-2033年产业预测

预计到 2024 年，神经血管导管市场规模将达到 34.8 亿美元，到 2025 年将达到 37.3 亿美元，到 2033 年将达到 65.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 7.2%。

神经血管导管市场正经历显着增长，其主要驱动因素包括脑动脉瘤和中风等神经系统疾病发病率的上升、生活方式的改变以及公众对治疗方案认知的提高。此外，可支配收入的增加和市场领导不断推出创新产品也进一步推动了这一成长。蛛网膜下腔出血发生率的上升凸显了市场的巨大需求，尤其是在新兴市场承担了相当一部分病例的情况下。导管设计的技术进步也预计将促进市场动态，例如新一代球囊引导管等创新技术将拓展急性缺血性脑中风的治疗选择。对各种神经血管通路技术的全面研究有助于临床疗效和效率的持续提升，从而进一步推动市场成长。

神经血管导管市场驱动因素

包括中风、动脉瘤和动静脉畸形（AVM）在内的神经系统疾病发生率不断上升，显着推动了对神经血管导管的需求。随着这些疾病的日益普遍，对有效诊断和治疗方案的需求也日益增长，使得神经血管导管成为医疗领域不可或缺的工具。这些专用器械对于医务人员准确诊断和治疗此类复杂疾病患者至关重要。因此，人们对解决神经系统健康问题的日益关注预计将继续推动神经血管导管市场的发展，这体现了这些器械在现代医学中的关键作用。

限制神经血管导管市场的因素

神经血管导管市场面临许多限制因素，主要源自于脑内复杂血管系统的进入与操作本身就极具挑战性。这种复杂性增加了出血、血栓形成、血管穿孔和感染等严重併发症的风险，这些併发症可能造成毁灭性后果，包括急性神经功能障碍甚至死亡。此外，这些併发症往往会导致住院时间延长和医疗成本增加。过去有健康问题的患者发生不利事件的风险更高，这进一步加剧了神经血管导管插入术的整体风险，从而影响市场动态。

神经血管导管市场趋势

受中风、动脉瘤和动静脉畸形等神经系统疾病发病率上升的推动，神经血管导管市场正经历显着增长。随着医疗机构日益寻求有效且微创的治疗方案，创新导管技术正获得广泛应用。医疗基础设施的进步以及人口老化加剧了这一趋势，因为老龄化人口更容易患上这些疾病。此外，持续的研发工作不断改善导管的设计和功能，从而改善患者预后并提高手术效率。因此，神经血管领域的相关人员已做好充分准备，把握市场对专用导管日益增长的需求，以应对这些重要的医疗挑战。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 专利分析

全球神经血管导管市场规模（按类型及复合年增长率划分）（2026-2033 年）

• 微导管
• 球囊导管
• 导管接入
• 栓塞导管
• 其他的

全球神经血管导管市场规模（按组件划分）及复合年增长率（2026-2033 年）

• 导管芯轴
• 导管衬垫
• 重新加热热缩管
• 尼龙管/Pebax
• 其他部分

全球神经血管导管市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 栓塞性中风
• 脑动脉瘤
• 动静脉畸形
• 其他的

全球神经血管导管市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 医院
• 诊所
• 门诊手术中心
• 诊断中心

全球神经血管导管市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Medtronic（Galway, Ireland）
• Boston Scientific（Marlborough, Massachusetts, USA）
• Stryker Corporation（Kalamazoo, Michigan, USA）
• Penumbra（Alameda, California, USA）
• Edwards Lifesciences（Irvine, California, USA）
• Terumo Corporation（Tokyo, Japan）
• Johnson & Johnson（New Brunswick, New Jersey, USA）
• Abbott Laboratories（Abbott Park, Illinois, USA）
• B. Braun Melsungen（Melsungen, Germany）
• MicroPort Scientific（Shanghai, China）
• Integer Holdings Corporation（Plano, Texas, USA）
• Cook Medical（Bloomington, Indiana, USA）
• Cardinal Health（Dublin, Ohio, USA）
• Smith & Nephew（London, United Kingdom）
• Teleflex Incorporated（Wayne, Pennsylvania, USA）
• Merit Medical Systems（South Jordan, Utah, USA）
• Nipro Corporation（Osaka, Japan）
• Asahi Intecc（Aichi, Japan）
• WL Gore & Associates（Newark, Delaware, USA）
• Convatec（London, United Kingdom）

结论与建议

Neurovascular Catheters Market size was valued at USD 3.48 Billion in 2024 and is poised to grow from USD 3.73 Billion in 2025 to USD 6.51 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The neurovascular catheter market is experiencing significant growth driven by the increasing incidence of neurological disorders such as brain aneurysms and strokes, coupled with lifestyle changes and enhanced public awareness regarding treatment options. Additionally, rising disposable incomes and the continuous introduction of innovative products by market leaders further propel this expansion. The prevalence of subarachnoid hemorrhage highlights a substantial market need, particularly as emerging markets bear a significant portion of this burden. Technological advancements in catheter designs are also expected to contribute to market dynamics, with innovations like next-generation balloon guide catheters enhancing treatment options for acute ischemic strokes. Comprehensive research into various neurovascular access methods supports continued improvement in clinical outcomes and efficiency, further fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Catheters market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurovascular Catheters Market Segments Analysis

Global Neurovascular Catheters Market is segmented by Type, Component, Application, End-use and region. Based on Type, the market is segmented into Microcatheters, Balloon Catheters, Access Catheters, Embolization Catheters and Others. Based on Component, the market is segmented into Catheter Mandrels, Catheter Liners, Reflow Heat Shrinks, Nylon Tubing/Pebax and Other Components. Based on Application, the market is segmented into Embolic Stroke, Brain Aneurysm, Arteriovenous Malformations and Others. Based on End-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurovascular Catheters Market

The increasing incidence of neurological conditions, including strokes, aneurysms, and arteriovenous malformations (AVMs), is significantly fueling the demand for neurovascular catheters. As these disorders become more common, the need for effective diagnostic and therapeutic solutions grows, making neurovascular catheters essential tools in medical practice. These specialized devices are crucial for enabling healthcare professionals to accurately diagnose and treat patients suffering from such complex conditions. Consequently, the heightened focus on addressing neurological health concerns is expected to continue driving the expansion of the neurovascular catheters market, reflecting the critical role these instruments play in modern healthcare.

Restraints in the Neurovascular Catheters Market

The neurovascular catheters market faces significant constraints primarily due to the inherent challenges of accessing and maneuvering through the intricate blood vessels in the brain. This complexity raises the potential for serious complications, including bleeding, clot formation, vessel perforation, and infection, which can have dire consequences such as acute neurological deficits or mortality. Furthermore, these complications often result in extended hospital stays and elevated healthcare expenses. The risk of adverse effects escalates in individuals with pre-existing health issues, compounding the overall risks associated with neurovascular catheter procedures and thereby influencing the market dynamics.

Market Trends of the Neurovascular Catheters Market

The neurovascular catheters market is experiencing significant growth, fueled by the rising prevalence of neurological disorders, including strokes, aneurysms, and arteriovenous malformations. As healthcare providers increasingly seek effective and minimally invasive treatment solutions, innovative catheter technologies are gaining traction. This trend is further supported by advancing healthcare infrastructure and a growing aging population susceptible to such ailments. Additionally, ongoing research and development efforts are enhancing catheter designs and functionalities, improving patient outcomes and procedural efficiency. Consequently, stakeholders in the neurovascular space are poised to capitalize on the heightened demand for specialized catheters to address these critical healthcare challenges.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Neurovascular Catheters Market Size by Type & CAGR (2026-2033)

• Market Overview
• Microcatheters
• Balloon Catheters
• Access Catheters
• Embolization Catheters
• Others

Global Neurovascular Catheters Market Size by Component & CAGR (2026-2033)

• Market Overview
• Catheter Mandrels
• Catheter Liners
• Reflow Heat Shrinks
• Nylon Tubing/Pebax
• Other Components

Global Neurovascular Catheters Market Size by Application & CAGR (2026-2033)

• Market Overview
• Embolic Stroke
• Brain Aneurysm
• Arteriovenous Malformations
• Others

Global Neurovascular Catheters Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers

Global Neurovascular Catheters Market Size & CAGR (2026-2033)

• North America (Type, Component, Application, End-use)
  • US
  • Canada
• Europe (Type, Component, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Component, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Component, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Component, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic (Galway, Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (Marlborough, Massachusetts, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (Kalamazoo, Michigan, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra (Alameda, California, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (Irvine, California, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Tokyo, Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (New Brunswick, New Jersey, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (Abbott Park, Illinois, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen (Melsungen, Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific (Shanghai, China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (Plano, Texas, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (Bloomington, Indiana, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (Dublin, Ohio, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew (London, United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (Wayne, Pennsylvania, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (South Jordan, Utah, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Osaka, Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc (Aichi, Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates (Newark, Delaware, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec (London, United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations